Emergent BioSolutions Inc.EBSNYSE
LOADING
|||
Switch Symbol:
Year-over-year operating income growth rate
| Period | Value |
|---|---|
| Q3 2025 | 4681.25% |
| Q2 2025 | -96.79% |
| Q1 2025 | 625.26% |
| Q4 2024 | -114.73% |
| Q3 2024 | 131.70% |
| Q2 2024 | -611.31% |
| Q1 2024 | 190.87% |
| Q4 2023 | 81.91% |
| Q3 2023 | 17.34% |
| Q2 2023 | -98.44% |
| Q1 2023 | -166.91% |
| Q4 2022 | -22.08% |
| Q3 2022 | 40.24% |
| Q2 2022 | -1284.38% |
| Q1 2022 | -97.69% |
| Q4 2021 | 899.42% |
| Q3 2021 | -339.31% |
| Q2 2021 | -84.80% |
| Q1 2021 | -63.04% |
| Q4 2020 | 321.04% |
| Q3 2020 | -51.35% |
| Q2 2020 | 1186.21% |
| Q1 2020 | -114.93% |
| Q4 2019 | 9.90% |
| Q3 2019 | 1110.00% |
| Q2 2019 | 74.26% |
| Q1 2019 | -342.86% |
| Q4 2018 | -47.42% |
| Q3 2018 | -68.11% |
| Q2 2018 | 803.16% |
| Q1 2018 | -117.89% |
| Q4 2017 | 11.14% |
| Q3 2017 | 460.08% |
| Q2 2017 | -42.80% |
| Q1 2017 | -70.72% |
| Q4 2016 | 43.55% |
| Q3 2016 | 1837.42% |
| Q2 2016 | -109.65% |
| Q1 2016 | -67.52% |
| Q4 2015 | 3.15% |